Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [153Sm]Sm-DOTA-TATE.
Vermeulen K, Van de Voorde M, Segers C, Coolkens A, Rodriguez Pérez S, Daems N, Duchemin C, Crabbé M, Opsomer T, Saldarriaga Vargas C, Heinke R, Lambert L, Bernerd C, Burgoyne AR, Cocolios TE, Stora T, Ooms M. Vermeulen K, et al. Among authors: duchemin c. Pharmaceutics. 2022 Nov 23;14(12):2566. doi: 10.3390/pharmaceutics14122566. Pharmaceutics. 2022. PMID: 36559060 Free PMC article.
Resonant laser ionization and mass separation of 225Ac.
Johnson JD, Heines M, Bruchertseifer F, Chevallay E, Cocolios TE, Dockx K, Duchemin C, Heinitz S, Heinke R, Hurier S, Lambert L, Leenders B, Skliarova H, Stora T, Wojtaczka W. Johnson JD, et al. Among authors: duchemin c. Sci Rep. 2023 Jan 24;13(1):1347. doi: 10.1038/s41598-023-28299-4. Sci Rep. 2023. PMID: 36693865 Free PMC article.
Target Development towards First Production of High-Molar- Activity 44gSc and 47Sc by Mass Separation at CERN-MEDICIS.
Mamis E, Duchemin C, Berlin V, Bernerd C, Bovigny M, Chevallay E, Crepieux B, Gadelshin VM, Heinke R, Hernandez RM, Johnson JD, Kalniņa P, Koliatos A, Lambert L, Rossel RE, Rothe S, Thiboud J, Weber F, Wendt K, Zabolockis RJ, Pajuste E, Stora T. Mamis E, et al. Among authors: duchemin c. Pharmaceuticals (Basel). 2024 Mar 18;17(3):390. doi: 10.3390/ph17030390. Pharmaceuticals (Basel). 2024. PMID: 38543176 Free PMC article.
Therapeutic efficacy of 166Holmium siloxane in microbrachytherapy of induced glioblastoma in minipig tumor model.
Khoshnevis M, Brown R, Belluco S, Zahi I, Maciocco L, Bonnefont-Rebeix C, Pillet-Michelland E, Tranel J, Roger T, Nennig C, Oudoire P, Marcon L, Tillement O, Louis C, Gehan H, Bardiès M, Mariani M, Muzio V, Meunier JP, Duchemin C, Michel N, N'Tsiba E, Haddad F, Buronfosse T, Carozzo C, Ponce F. Khoshnevis M, et al. Among authors: duchemin c. Front Oncol. 2022 Nov 7;12:923679. doi: 10.3389/fonc.2022.923679. eCollection 2022. Front Oncol. 2022. PMID: 36419904 Free PMC article.
Half-life determination of 155Tb from mass-separated samples produced at CERN-MEDICIS.
Collins SM, Robinson AP, Ivanov P, Köster U, Cocolios TE, Russell B, Webster B, Fenwick AJ, Duchemin C, Ramos JP, Chevallay E, Jakobsson U, Stegemann S, Regan PH, Stora T. Collins SM, et al. Among authors: duchemin c. Appl Radiat Isot. 2022 Dec;190:110480. doi: 10.1016/j.apradiso.2022.110480. Epub 2022 Sep 24. Appl Radiat Isot. 2022. PMID: 36209648 Free article.
Efficient Production of High Specific Activity Thulium-167 at Paul Scherrer Institute and CERN-MEDICIS.
Heinke R, Chevallay E, Chrysalidis K, Cocolios TE, Duchemin C, Fedosseev VN, Hurier S, Lambert L, Leenders B, Marsh BA, van der Meulen NP, Sprung P, Stora T, Tosato M, Wilkins SG, Zhang H, Talip Z. Heinke R, et al. Among authors: duchemin c. Front Med (Lausanne). 2021 Oct 12;8:712374. doi: 10.3389/fmed.2021.712374. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34712674 Free PMC article.
38 results